Cargando…
Atrial Fibrillation and Heart Failure
Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and has a strong association with heart failure (HF). It often remains unclear if HF is the cause or consequence of AF due to the complexity of the processes that are involved in both the perpetuation of AF and the developmen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103974/ https://www.ncbi.nlm.nih.gov/pubmed/35566639 http://dx.doi.org/10.3390/jcm11092510 |
_version_ | 1784707681583366144 |
---|---|
author | Bergau, Leonard Bengel, Philipp Sciacca, Vanessa Fink, Thomas Sohns, Christian Sommer, Philipp |
author_facet | Bergau, Leonard Bengel, Philipp Sciacca, Vanessa Fink, Thomas Sohns, Christian Sommer, Philipp |
author_sort | Bergau, Leonard |
collection | PubMed |
description | Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and has a strong association with heart failure (HF). It often remains unclear if HF is the cause or consequence of AF due to the complexity of the processes that are involved in both the perpetuation of AF and the development of HF. To date, two therapeutic strategies are accepted as the standard of care in AF patients with heart failure. Rhythm control aims to permanently restore sinus rhythm, whereas a rate-control strategy aims to slow ventricular rate without the termination of AF. In the last 5 years a tremendous number of important studies have been published investigating the optimal therapeutic strategy in HF patients. This review highlights the important studies with respect to the involvement of AF in promoting left-ventricular dysfunction and discusses the optimal strategy in HF patients suffering from AF. |
format | Online Article Text |
id | pubmed-9103974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91039742022-05-14 Atrial Fibrillation and Heart Failure Bergau, Leonard Bengel, Philipp Sciacca, Vanessa Fink, Thomas Sohns, Christian Sommer, Philipp J Clin Med Review Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and has a strong association with heart failure (HF). It often remains unclear if HF is the cause or consequence of AF due to the complexity of the processes that are involved in both the perpetuation of AF and the development of HF. To date, two therapeutic strategies are accepted as the standard of care in AF patients with heart failure. Rhythm control aims to permanently restore sinus rhythm, whereas a rate-control strategy aims to slow ventricular rate without the termination of AF. In the last 5 years a tremendous number of important studies have been published investigating the optimal therapeutic strategy in HF patients. This review highlights the important studies with respect to the involvement of AF in promoting left-ventricular dysfunction and discusses the optimal strategy in HF patients suffering from AF. MDPI 2022-04-29 /pmc/articles/PMC9103974/ /pubmed/35566639 http://dx.doi.org/10.3390/jcm11092510 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bergau, Leonard Bengel, Philipp Sciacca, Vanessa Fink, Thomas Sohns, Christian Sommer, Philipp Atrial Fibrillation and Heart Failure |
title | Atrial Fibrillation and Heart Failure |
title_full | Atrial Fibrillation and Heart Failure |
title_fullStr | Atrial Fibrillation and Heart Failure |
title_full_unstemmed | Atrial Fibrillation and Heart Failure |
title_short | Atrial Fibrillation and Heart Failure |
title_sort | atrial fibrillation and heart failure |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103974/ https://www.ncbi.nlm.nih.gov/pubmed/35566639 http://dx.doi.org/10.3390/jcm11092510 |
work_keys_str_mv | AT bergauleonard atrialfibrillationandheartfailure AT bengelphilipp atrialfibrillationandheartfailure AT sciaccavanessa atrialfibrillationandheartfailure AT finkthomas atrialfibrillationandheartfailure AT sohnschristian atrialfibrillationandheartfailure AT sommerphilipp atrialfibrillationandheartfailure |